OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic Targets and Emerging Treatments in Advanced Chondrosarcoma
Shinji Miwa, Norio Yamamoto, Katsuhiro Hayashi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1096-1096
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Collagen Remodeling along Cancer Progression Providing a Novel Opportunity for Cancer Diagnosis and Treatment
Kena Song, Zhangqing Yu, Xiangyang Zu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10509-10509
Open Access | Times Cited: 49

Classification of Chondrosarcoma: From Characteristic to Challenging Imaging Findings
Jun‐Ho Kim, Seul Ki Lee
Cancers (2023) Vol. 15, Iss. 6, pp. 1703-1703
Open Access | Times Cited: 41

Preclinical Characterization and Phase I Trial Results of INBRX-109, A Third-Generation, Recombinant, Humanized, Death Receptor 5 Agonist Antibody, in Chondrosarcoma
Vivek Subbiah, Sant P. Chawla, Anthony P. Conley, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 16, pp. 2988-3003
Open Access | Times Cited: 26

Chondrosarcoma Resistance to Radiation Therapy: Origins and Potential Therapeutic Solutions
Antoine Gilbert, Mihaela Tudor, Juliette Montanari, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 1962-1962
Open Access | Times Cited: 24

Surgical Treatment of Bone Sarcoma
Felix Bläsius, Heide Delbrück, Frank Hildebrand, et al.
Cancers (2022) Vol. 14, Iss. 11, pp. 2694-2694
Open Access | Times Cited: 33

Development of Injectable Thermosensitive Nanocomposite Hydrogel for Ratiometric Drug Delivery to Treat Drug Resistant Chondrosarcoma In Vivo
Jiahui Zhu, Ran Wei, Guang Hu, et al.
Small (2024) Vol. 20, Iss. 31
Closed Access | Times Cited: 5

Emerging Treatments Targeting the Tumor Microenvironment for Advanced Chondrosarcoma
Vincenzo Ingangi, Annarosaria De Chiara, Gerardo Ferrara, et al.
Cells (2024) Vol. 13, Iss. 11, pp. 977-977
Open Access | Times Cited: 4

DNA methyltransferase 3A: A prognostic biomarker and potential target for immunotherapy in gastric cancer
Zhou Wei, Zhenzhen Kou, Yun Luo, et al.
Medicine (2025) Vol. 104, Iss. 7, pp. e41578-e41578
Open Access

Application of patient derived xenograft model in personalized drug screening for chondrosarcoma of head and neck: A preclinical study
Yufei Hua, Zhiyong Guo, Ying Wang, et al.
Oral Oncology (2025) Vol. 162, pp. 107222-107222
Closed Access

Maxillary aggressive chondrosarcoma: A rare and challenging case
Fadila Kouhen, Malak Chahid, Reyzane El Mjabber, et al.
Radiology Case Reports (2025) Vol. 20, Iss. 5, pp. 2521-2526
Closed Access

Epigenetic Abnormalities in Chondrosarcoma
Michał Bereza, Mateusz Dembiński, Agnieszka Zając, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4539-4539
Open Access | Times Cited: 9

Sarcoma: Molecular Pathology, Diagnostics, and Therapeutics
Shinji Miwa, Norio Yamamoto, Hiroyuki Tsuchiya
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5833-5833
Open Access | Times Cited: 7

New advances in the treatment of chondrosarcoma under the PD-1/PD-L1 pathway
Jiawei Yin, Peng Ren
Journal of Cancer Research and Therapeutics (2024) Vol. 20, Iss. 2, pp. 522-530
Open Access | Times Cited: 2

Dedifferentiated Chondrosarcoma from Molecular Pathology to Current Treatment and Clinical Trials
Weronika Zając, Julia Dróżdż, Weronika Kisielewska, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3924-3924
Open Access | Times Cited: 5

Advancing the Management of Skull Base Chondrosarcomas: A Systematic Review of Targeted Therapies
Edoardo Agosti, Marco Zeppieri, Sara Antonietti, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 3, pp. 261-261
Open Access | Times Cited: 1

The Effects and Mechanisms of Sennoside A on Inducing Cytotoxicity, Apoptosis, and Inhibiting Metastasis in Human Chondrosarcoma Cells
Jiamei Le, Houlin Ji, Peixian Pi, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 5

Current status and future directions of systemic therapy in high-grade bone sarcomas
Gennady N. Machak
N N Priorov Journal of Traumatology and Orthopedics (2024) Vol. 31, Iss. 2, pp. 229-249
Open Access

Keratin 17 and Collagen type 1 genes: Esophageal cancer molecular marker discovery and evaluation
Huiwen Pan, Jie Hong, Aizhong Shao, et al.
The Clinical Respiratory Journal (2024) Vol. 18, Iss. 7
Open Access

Multiple enchondromas in Ollier's disease: A case report
Jeremy Hugh Yen-hey Lau, Koon Kiu Ng, Wai Chung Wong, et al.
Radiology Case Reports (2024) Vol. 19, Iss. 11, pp. 5033-5037
Open Access

Impact of the Pretreatment Neutrophil/Lymphocyte Ratio as a Prognostic Factor in Conventional Chondrosarcoma
M A Clara-Altamirano, Amelia Rebeca de Los Santos-Quintanilla, Kuauhyama Luna‐Ortiz, et al.
Indian Journal of Surgical Oncology (2024)
Closed Access

RNF2 promotes chondrosarcoma progression by regulating ubiquitination and degradation of CBX7
Yue Wu, Zheng Huang, Ping Luo, et al.
Cancer & Metabolism (2024) Vol. 12, Iss. 1
Open Access

Genetics and Molecular Pathogenesis of the Chondrosarcoma: A Review of the Literature
Georgian-Longin Iacobescu, Antonio-Daniel Corlatescu, Bogdan Șerban, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 11, pp. 12658-12671
Open Access

Research trends and foci in chondrosarcoma: A bibliometric and network analysis
Yuming Yao, Ruhao Zhou, Guang Yang, et al.
Medicine (2024) Vol. 103, Iss. 45, pp. e40403-e40403
Open Access

Page 1 - Next Page

Scroll to top